Atrium Mortgage Investment Corporation
Get $10 bonus on your first $100 deposit for AMIVF
Get $10 bonus on your first $100 deposit for AMIVF
Atrium Mortgage Investment Corporation (AMIVF) Stock Competitors & Peer Comparison
See (AMIVF) competitors and their performances in Stock Market.
Peer Comparison Table: Financial - Mortgages Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMIVF | $8.31 | +0.00% | 399.1M | 11.23 | $0.74 | +9.00% |
| FMCCT | $18.20 | -1.09% | 11.8B | 267.65 | $0.07 | N/A |
| FNMFO | $42,000.00 | +5.00% | 10.5B | 6000000.00 | $0.01 | N/A |
| FMCKK | $15.00 | +0.00% | 9.8B | -1071.43 | -$0.01 | N/A |
| FNMAS | $12.00 | -1.56% | 9.4B | 1714.29 | $0.01 | N/A |
| FNMFN | $19.84 | +4.15% | 9.2B | 2834.29 | $0.01 | N/A |
| FNMAI | $10.00 | +4.17% | 9B | 1428.57 | $0.01 | N/A |
| FNMAP | $14.98 | -8.38% | 9B | 2140.00 | $0.01 | N/A |
| FNMAG | $18.00 | +9.09% | 8.9B | 2571.43 | $0.01 | N/A |
| FNMAJ | $9.94 | -3.31% | 8.7B | 1420.00 | $0.01 | N/A |
Stock Comparison
AMIVF vs FMCCT Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCT has a market cap of 11.8B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCT trades at $18.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCT's P/E ratio is 267.65. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCT's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCCT. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCCT's competition here
AMIVF vs FNMFO Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMFO has a market cap of 10.5B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMFO trades at $42,000.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMFO's P/E ratio is 6000000.00. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMFO's ROE of +0.14%. Regarding short-term risk, AMIVF is more volatile compared to FNMFO. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FNMFO's competition here
AMIVF vs FMCKK Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCKK has a market cap of 9.8B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCKK trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCKK's P/E ratio is -1071.43. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCKK's ROE of +0.16%. Regarding short-term risk, AMIVF is more volatile compared to FMCKK. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FMCKK's competition here
AMIVF vs FNMAS Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAS has a market cap of 9.4B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAS trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAS's P/E ratio is 1714.29. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAS's ROE of +0.14%. Regarding short-term risk, AMIVF is less volatile compared to FNMAS. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FNMAS's competition here
AMIVF vs FNMFN Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMFN has a market cap of 9.2B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMFN trades at $19.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMFN's P/E ratio is 2834.29. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMFN's ROE of +0.14%. Regarding short-term risk, AMIVF is less volatile compared to FNMFN. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FNMFN's competition here
AMIVF vs FNMAI Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAI has a market cap of 9B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAI trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAI's P/E ratio is 1428.57. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAI's ROE of +0.14%. Regarding short-term risk, AMIVF is less volatile compared to FNMAI. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FNMAI's competition here
AMIVF vs FNMAP Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAP has a market cap of 9B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAP trades at $14.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAP's P/E ratio is 2140.00. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAP's ROE of +0.14%. Regarding short-term risk, AMIVF is less volatile compared to FNMAP. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FNMAP's competition here
AMIVF vs FNMAG Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAG has a market cap of 8.9B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAG trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAG's P/E ratio is 2571.43. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAG's ROE of +0.14%. Regarding short-term risk, AMIVF is less volatile compared to FNMAG. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FNMAG's competition here
AMIVF vs FNMAJ Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAJ has a market cap of 8.7B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAJ trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAJ's P/E ratio is 1420.00. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAJ's ROE of +0.14%. Regarding short-term risk, AMIVF is less volatile compared to FNMAJ. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FNMAJ's competition here
AMIVF vs FNMAH Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAH has a market cap of 8.6B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAH trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAH's P/E ratio is 1278.57. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAH's ROE of +0.14%. Regarding short-term risk, AMIVF is less volatile compared to FNMAH. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FNMAH's competition here
AMIVF vs FNMAN Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAN has a market cap of 8.6B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAN trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAN's P/E ratio is 2321.43. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAN's ROE of +0.14%. Regarding short-term risk, AMIVF is less volatile compared to FNMAN. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FNMAN's competition here
AMIVF vs FNMAK Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAK has a market cap of 8.4B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAK trades at $17.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAK's P/E ratio is 2428.57. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAK's ROE of +0.14%. Regarding short-term risk, AMIVF is more volatile compared to FNMAK. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FNMAK's competition here
AMIVF vs FNMAM Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAM has a market cap of 8.3B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAM trades at $17.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAM's P/E ratio is 2462.86. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAM's ROE of +0.14%. Regarding short-term risk, AMIVF is more volatile compared to FNMAM. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FNMAM's competition here
AMIVF vs FNMAL Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAL has a market cap of 8.3B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAL trades at $15.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAL's P/E ratio is 2257.14. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAL's ROE of +0.14%. Regarding short-term risk, AMIVF is more volatile compared to FNMAL. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FNMAL's competition here
AMIVF vs FNMAT Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAT has a market cap of 8.2B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAT trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAT's P/E ratio is 1428.57. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAT's ROE of +0.14%. Regarding short-term risk, AMIVF is less volatile compared to FNMAT. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FNMAT's competition here
AMIVF vs FNMA Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMA has a market cap of 8B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMA trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMA's P/E ratio is N/A. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMA's ROE of +0.14%. Regarding short-term risk, AMIVF is less volatile compared to FNMA. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FNMA's competition here
AMIVF vs FNMFM Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMFM has a market cap of 7.9B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMFM trades at $14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMFM's P/E ratio is 2071.43. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMFM's ROE of +0.14%. Regarding short-term risk, AMIVF is more volatile compared to FNMFM. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FNMFM's competition here
AMIVF vs FNMAO Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNMAO has a market cap of 7.8B. Regarding current trading prices, AMIVF is priced at $8.31, while FNMAO trades at $14.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNMAO's P/E ratio is 2138.57. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNMAO's ROE of +0.14%. Regarding short-term risk, AMIVF is more volatile compared to FNMAO. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FNMAO's competition here
AMIVF vs FMCKJ Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCKJ has a market cap of 7.5B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCKJ trades at $11.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCKJ's P/E ratio is 168.97. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCKJ's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCKJ. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCKJ's competition here
AMIVF vs FMCKN Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCKN has a market cap of 4.4B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCKN trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCKN's P/E ratio is 150.74. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCKN's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCKN. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCKN's competition here
AMIVF vs FMCCK Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCK has a market cap of 4.1B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCK trades at $16.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCK's P/E ratio is 247.21. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCK's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCCK. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCCK's competition here
AMIVF vs FMCCP Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCP has a market cap of 4.1B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCP trades at $17.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCP's P/E ratio is 255.15. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCP's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCCP. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCCP's competition here
AMIVF vs FREJN Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FREJN has a market cap of 4.1B. Regarding current trading prices, AMIVF is priced at $8.31, while FREJN trades at $16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FREJN's P/E ratio is 242.65. In terms of profitability, AMIVF's ROE is +0.09%, compared to FREJN's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FREJN. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FREJN's competition here
AMIVF vs FMCCH Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCH has a market cap of 4.1B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCH trades at $15.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCH's P/E ratio is 235.15. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCH's ROE of +0.16%. Regarding short-term risk, AMIVF is more volatile compared to FMCCH. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FMCCH's competition here
AMIVF vs FMCCO Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCO has a market cap of 4B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCO trades at $16.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCO's P/E ratio is 245.15. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCO's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCCO. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCCO's competition here
AMIVF vs FMCKI Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCKI has a market cap of 4B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCKI trades at $9.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCKI's P/E ratio is 137.22. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCKI's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCKI. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCKI's competition here
AMIVF vs FMCCS Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCS has a market cap of 4B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCS trades at $15.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCS's P/E ratio is 226.03. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCS's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCCS. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCCS's competition here
AMIVF vs FMCKM Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCKM has a market cap of 3.9B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCKM trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCKM's P/E ratio is 136.03. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCKM's ROE of +0.16%. Regarding short-term risk, AMIVF is more volatile compared to FMCKM. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FMCKM's competition here
AMIVF vs FMCCL Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCL has a market cap of 3.9B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCL trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCL's P/E ratio is 219.12. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCL's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCCL. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCCL's competition here
AMIVF vs FMCC Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCC has a market cap of 3.9B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCC trades at $6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCC's P/E ratio is -301.50. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCC's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCC. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCC's competition here
AMIVF vs FMCKP Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCKP has a market cap of 3.9B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCKP trades at $16.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCKP's P/E ratio is 249.56. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCKP's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCKP. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCKP's competition here
AMIVF vs FREGP Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FREGP has a market cap of 3.9B. Regarding current trading prices, AMIVF is priced at $8.31, while FREGP trades at $16.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FREGP's P/E ratio is 241.76. In terms of profitability, AMIVF's ROE is +0.09%, compared to FREGP's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FREGP. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FREGP's competition here
AMIVF vs FMCKL Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCKL has a market cap of 3.8B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCKL trades at $9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCKL's P/E ratio is 138.24. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCKL's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCKL. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCKL's competition here
AMIVF vs FMCKO Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCKO has a market cap of 3.8B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCKO trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCKO's P/E ratio is 141.18. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCKO's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCKO. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCKO's competition here
AMIVF vs FMCCI Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCI has a market cap of 3.8B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCI trades at $14.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCI's P/E ratio is 209.56. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCI's ROE of +0.16%. Regarding short-term risk, AMIVF is more volatile compared to FMCCI. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FMCCI's competition here
AMIVF vs FMCCM Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCM has a market cap of 3.7B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCM trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCM's P/E ratio is 205.88. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCM's ROE of +0.16%. Regarding short-term risk, AMIVF is more volatile compared to FMCCM. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FMCCM's competition here
AMIVF vs FMCCN Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCN has a market cap of 3.7B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCN trades at $13.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCN's P/E ratio is 203.97. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCN's ROE of +0.16%. Regarding short-term risk, AMIVF is more volatile compared to FMCCN. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FMCCN's competition here
AMIVF vs FMCCG Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCG has a market cap of 3.6B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCG trades at $14.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCG's P/E ratio is 207.50. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCG's ROE of +0.16%. Regarding short-term risk, AMIVF is less volatile compared to FMCCG. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check FMCCG's competition here
AMIVF vs FMCCJ Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FMCCJ has a market cap of 3.5B. Regarding current trading prices, AMIVF is priced at $8.31, while FMCCJ trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FMCCJ's P/E ratio is 191.18. In terms of profitability, AMIVF's ROE is +0.09%, compared to FMCCJ's ROE of +0.16%. Regarding short-term risk, AMIVF is more volatile compared to FMCCJ. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FMCCJ's competition here
AMIVF vs FNLIF Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FNLIF has a market cap of 2.1B. Regarding current trading prices, AMIVF is priced at $8.31, while FNLIF trades at $34.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FNLIF's P/E ratio is 15.63. In terms of profitability, AMIVF's ROE is +0.09%, compared to FNLIF's ROE of +0.21%. Regarding short-term risk, AMIVF is more volatile compared to FNLIF. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FNLIF's competition here
AMIVF vs HMCBF Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, HMCBF has a market cap of 1.2B. Regarding current trading prices, AMIVF is priced at $8.31, while HMCBF trades at $32.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas HMCBF's P/E ratio is 9.85. In terms of profitability, AMIVF's ROE is +0.09%, compared to HMCBF's ROE of +0.10%. Regarding short-term risk, AMIVF is more volatile compared to HMCBF. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check HMCBF's competition here
AMIVF vs MAMTF Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, MAMTF has a market cap of 664.8M. Regarding current trading prices, AMIVF is priced at $8.31, while MAMTF trades at $16.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas MAMTF's P/E ratio is 12.04. In terms of profitability, AMIVF's ROE is +0.09%, compared to MAMTF's ROE of +0.12%. Regarding short-term risk, AMIVF is more volatile compared to MAMTF. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check MAMTF's competition here
AMIVF vs BRLGF Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, BRLGF has a market cap of 527M. Regarding current trading prices, AMIVF is priced at $8.31, while BRLGF trades at $6.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas BRLGF's P/E ratio is 31.05. In terms of profitability, AMIVF's ROE is +0.09%, compared to BRLGF's ROE of +0.18%. Regarding short-term risk, AMIVF is more volatile compared to BRLGF. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check BRLGF's competition here
AMIVF vs TBCRF Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, TBCRF has a market cap of 398M. Regarding current trading prices, AMIVF is priced at $8.31, while TBCRF trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas TBCRF's P/E ratio is 16.03. In terms of profitability, AMIVF's ROE is +0.09%, compared to TBCRF's ROE of +0.05%. Regarding short-term risk, AMIVF is less volatile compared to TBCRF. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check TBCRF's competition here
AMIVF vs FCMGF Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FCMGF has a market cap of 314.1M. Regarding current trading prices, AMIVF is priced at $8.31, while FCMGF trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FCMGF's P/E ratio is 11.71. In terms of profitability, AMIVF's ROE is +0.09%, compared to FCMGF's ROE of +0.09%. Regarding short-term risk, AMIVF is more volatile compared to FCMGF. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FCMGF's competition here
AMIVF vs CFSU Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, CFSU has a market cap of 116.2M. Regarding current trading prices, AMIVF is priced at $8.31, while CFSU trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas CFSU's P/E ratio is -0.66. In terms of profitability, AMIVF's ROE is +0.09%, compared to CFSU's ROE of -0.01%. Regarding short-term risk, AMIVF is more volatile compared to CFSU. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check CFSU's competition here
AMIVF vs TFCCF Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, TFCCF has a market cap of 29.8M. Regarding current trading prices, AMIVF is priced at $8.31, while TFCCF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas TFCCF's P/E ratio is 23.19. In terms of profitability, AMIVF's ROE is +0.09%, compared to TFCCF's ROE of +0.03%. Regarding short-term risk, AMIVF is more volatile compared to TFCCF. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check TFCCF's competition here
AMIVF vs DVLN Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, DVLN has a market cap of 18.1M. Regarding current trading prices, AMIVF is priced at $8.31, while DVLN trades at $3,400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas DVLN's P/E ratio is 15.29. In terms of profitability, AMIVF's ROE is +0.09%, compared to DVLN's ROE of -0.07%. Regarding short-term risk, AMIVF is more volatile compared to DVLN. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check DVLN's competition here
AMIVF vs YBRHF Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, YBRHF has a market cap of 13.2M. Regarding current trading prices, AMIVF is priced at $8.31, while YBRHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas YBRHF's P/E ratio is -4.01. In terms of profitability, AMIVF's ROE is +0.09%, compared to YBRHF's ROE of N/A. Regarding short-term risk, AMIVF is more volatile compared to YBRHF. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check YBRHF's competition here
AMIVF vs VRTB Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, VRTB has a market cap of 7.3M. Regarding current trading prices, AMIVF is priced at $8.31, while VRTB trades at $3,105.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas VRTB's P/E ratio is -0.68. In terms of profitability, AMIVF's ROE is +0.09%, compared to VRTB's ROE of -4.05%. Regarding short-term risk, AMIVF is more volatile compared to VRTB. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check VRTB's competition here
AMIVF vs TNSGF Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, TNSGF has a market cap of 3.4M. Regarding current trading prices, AMIVF is priced at $8.31, while TNSGF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas TNSGF's P/E ratio is -12.00. In terms of profitability, AMIVF's ROE is +0.09%, compared to TNSGF's ROE of -0.01%. Regarding short-term risk, AMIVF is more volatile compared to TNSGF. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check TNSGF's competition here
AMIVF vs LFLS Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, LFLS has a market cap of 3M. Regarding current trading prices, AMIVF is priced at $8.31, while LFLS trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas LFLS's P/E ratio is 7.14. In terms of profitability, AMIVF's ROE is +0.09%, compared to LFLS's ROE of -0.03%. Regarding short-term risk, AMIVF is more volatile compared to LFLS. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check LFLS's competition here
AMIVF vs IMPM Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, IMPM has a market cap of 2.6M. Regarding current trading prices, AMIVF is priced at $8.31, while IMPM trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas IMPM's P/E ratio is -0.03. In terms of profitability, AMIVF's ROE is +0.09%, compared to IMPM's ROE of +2.17%. Regarding short-term risk, AMIVF is less volatile compared to IMPM. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check IMPM's competition here
AMIVF vs FCRM Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, FCRM has a market cap of 702.5K. Regarding current trading prices, AMIVF is priced at $8.31, while FCRM trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas FCRM's P/E ratio is -0.41. In terms of profitability, AMIVF's ROE is +0.09%, compared to FCRM's ROE of -0.19%. Regarding short-term risk, AMIVF is more volatile compared to FCRM. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check FCRM's competition here
AMIVF vs VAYK Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, VAYK has a market cap of 648.2K. Regarding current trading prices, AMIVF is priced at $8.31, while VAYK trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas VAYK's P/E ratio is -0.02. In terms of profitability, AMIVF's ROE is +0.09%, compared to VAYK's ROE of -0.14%. Regarding short-term risk, AMIVF is less volatile compared to VAYK. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check VAYK's competition here
AMIVF vs STXMF Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, STXMF has a market cap of 14.9K. Regarding current trading prices, AMIVF is priced at $8.31, while STXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas STXMF's P/E ratio is N/A. In terms of profitability, AMIVF's ROE is +0.09%, compared to STXMF's ROE of -0.92%. Regarding short-term risk, AMIVF is less volatile compared to STXMF. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check STXMF's competition here
AMIVF vs RFNS Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, RFNS has a market cap of 12.5K. Regarding current trading prices, AMIVF is priced at $8.31, while RFNS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas RFNS's P/E ratio is N/A. In terms of profitability, AMIVF's ROE is +0.09%, compared to RFNS's ROE of +5.79%. Regarding short-term risk, AMIVF is less volatile compared to RFNS. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check RFNS's competition here
AMIVF vs NFSE Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, NFSE has a market cap of 6.4K. Regarding current trading prices, AMIVF is priced at $8.31, while NFSE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas NFSE's P/E ratio is N/A. In terms of profitability, AMIVF's ROE is +0.09%, compared to NFSE's ROE of -2.55%. Regarding short-term risk, AMIVF is less volatile compared to NFSE. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check NFSE's competition here
AMIVF vs SOHI Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, SOHI has a market cap of 3.2K. Regarding current trading prices, AMIVF is priced at $8.31, while SOHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas SOHI's P/E ratio is N/A. In terms of profitability, AMIVF's ROE is +0.09%, compared to SOHI's ROE of +0.40%. Regarding short-term risk, AMIVF is less volatile compared to SOHI. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check SOHI's competition here
AMIVF vs DOMR Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, DOMR has a market cap of 785. Regarding current trading prices, AMIVF is priced at $8.31, while DOMR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas DOMR's P/E ratio is N/A. In terms of profitability, AMIVF's ROE is +0.09%, compared to DOMR's ROE of +0.70%. Regarding short-term risk, AMIVF is less volatile compared to DOMR. This indicates potentially lower risk in terms of short-term price fluctuations for AMIVF.Check DOMR's competition here
AMIVF vs TWAC Comparison April 2026
AMIVF plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMIVF stands at 399.1M. In comparison, TWAC has a market cap of 0. Regarding current trading prices, AMIVF is priced at $8.31, while TWAC trades at $140.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMIVF currently has a P/E ratio of 11.23, whereas TWAC's P/E ratio is N/A. In terms of profitability, AMIVF's ROE is +0.09%, compared to TWAC's ROE of N/A. Regarding short-term risk, AMIVF is more volatile compared to TWAC. This indicates potentially higher risk in terms of short-term price fluctuations for AMIVF.Check TWAC's competition here